Skip to NavigationSkip to content

News

After having been knocked by twice by NICE, Roche has finally received a recommendation for Tecentriq’s second-line use in non-small cell lung cancer.
Incyte's IDO1 inhibitor epacadostat, when applied in combination with MSD’s Keytruda, failed to meet its primary endpoint of improving progression...
Vas Narasimhan’s first few moves as CEO of Novartis indicate that he is not afraid to take bold risks in order to shape the future of the company and...
Partners Biogen and Samsung Bioepis have penned a deal with Abbvie which grants patent licenses for the sale of the product in Europe and the US...
Check out the week's ten most popular articles on Pharmafile.com now.
After Roche received Europe approval at the beginning of this year for Ocrevus, it would have been hoping to consolidate these sales but NICE has...
Johnson & Johnson has been ordered to pay out $37 million in damages after losing the first trial in a legal dispute which alleges that its Baby...
Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical but its CEO has now...
Nordic Nanovector has revealed that its Chief Executive Officer Luigi Costa is set to step down from his role at the company, with the decision...
Back in 2014, Roche entered into strategic collaboration with Inception Sciences to look into the regenerative medicines space for multiple sclerosis...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches